Movatterモバイル変換


[0]ホーム

URL:


CN112940071B - A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide - Google Patents

A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide
Download PDF

Info

Publication number
CN112940071B
CN112940071BCN202110148412.XACN202110148412ACN112940071BCN 112940071 BCN112940071 BCN 112940071BCN 202110148412 ACN202110148412 ACN 202110148412ACN 112940071 BCN112940071 BCN 112940071B
Authority
CN
China
Prior art keywords
cysteine
reaction
reaction solution
alkynyl
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110148412.XA
Other languages
Chinese (zh)
Other versions
CN112940071A (en
Inventor
郭凯
覃龙州
邱江凯
袁鑫
孙蕲
段秀
张欣鹏
刘杰
吴蒙雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech UniversityfiledCriticalNanjing Tech University
Priority to CN202110148412.XApriorityCriticalpatent/CN112940071B/en
Publication of CN112940071ApublicationCriticalpatent/CN112940071A/en
Application grantedgrantedCritical
Publication of CN112940071BpublicationCriticalpatent/CN112940071B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Images

Classifications

Landscapes

Abstract

The invention discloses a method for realizing alkynyl functionalization of cysteine and polypeptides thereof by utilizing a microchannel reactor, which comprises the following steps: (1) Dissolving cysteine or polypeptide containing cysteine shown in formula I in a first solvent to obtain a first reaction solution; (2) Dissolving an alkynyl functionalization reagent in a second solvent to serve as a second reaction solution; (3) Pumping the first reaction liquid and the second reaction liquid into a micro-channel reactor respectively and simultaneously for reaction, and collecting effluent liquid to obtain the reaction liquid containing cysteine shown in the formula II or the alkynyl functional product of the polypeptide containing cysteine. The invention relates to a brand-new method for realizing alkynyl functional modification of cysteine and polypeptide thereof, which can realize alkynyl functional modification of cysteine and polypeptide thereof only by adding organic alkali into a reaction system.

Description

Method for realizing alkynyl functionalization of cysteine and polypeptide thereof by utilizing microchannel reactor
Technical Field
The invention belongs to the field of chemical synthesis, and particularly relates to a method for realizing alkynyl functionalization of cysteine and polypeptides thereof by utilizing a microchannel reactor.
Background
Cysteine is one of 20 common amino acids that has important applications in a number of fields, for example: cysteine can be used as a raw material for synthesizing glutathione in a living body, and the glutathione is an important antioxidant substance in the living body; cysteine also has applications in the fields of pharmaceutical molecules and food processing; in addition, because cysteine contains a sulfhydryl structure, quantitative detection of the sulfhydryl content in a living body can be used as a judgment basis for related diseases, and the cysteine is also an important research object for scientific researchers.
Currently, methods for realizing alkynyl functional modification of cysteine and polypeptides thereof by using a micro-flow field reaction technology are also recently reported, and a method for realizing amino acid arylation by using aniline and cysteine under an illumination condition is reported by Timothy Noel in 2017 (Angew.chem.int.ed.2017, 56, 12702-12707). Although the reaction can effectively realize the arylation of amino acid, a photocatalyst and an oxidant are added into a reaction system. In 2018, veronique Gouverneur reported a method for performing difluoromethylation modification of cysteine-containing polypeptides using Umemoto reagent (j.am. Chem. Soc.2018,140, 1572-1575). Although the method has a good substrate range, the reaction yield is low, the synthesis scale is small, and the research of a scale-up experiment cannot be carried out. The traditional method for functionally modifying the cysteine often has the defects of needing to use noble metal as a catalyst, having low atom utilization rate, being not friendly to the environment and the like, and the defects limit the application of the method in industrialization. Therefore, it is very interesting to develop a catalyst-free, mild reaction conditions, environmentally friendly and easily scalable method for cysteine functionalization modification.
Disclosure of Invention
The invention aims to: the invention aims to solve the technical problem of providing a method for realizing alkynyl functionalization of cysteine and polypeptides thereof by utilizing a microchannel reactor aiming at the defects of the prior art.
In order to solve the technical problems, the invention discloses a method for realizing alkynyl functionalization of cysteine and polypeptides thereof by utilizing a microchannel reactor, as shown in fig. 1, comprising the following steps:
(1) Dissolving cysteine or polypeptide containing cysteine shown in formula I in a first solvent to obtain a first reaction solution;
(2) Dissolving an alkynyl functionalization reagent in a second solvent to serve as a second reaction solution;
(3) Pumping the first reaction liquid and the second reaction liquid into a micro-channel reactor respectively and simultaneously for reaction, and collecting effluent liquid to obtain a reaction liquid containing cysteine shown in a formula II or an alkynyl functional product of the polypeptide containing cysteine;
Figure BDA0002931122170000021
wherein,,
R1 selected from hydrogen, methyl, ethyl, propyl or isopropyl, preferably methyl;
R2 selected from-Ac (acetyl), -Boc (t-butoxycarbonyl), -Cbz (benzyloxycarbonyl), -Ts (p-toluenesulfonyl), -Fmoc (fluorenylmethoxycarbonyl) or other cysteine-linked amino acids, preferably other cysteine-linked amino acids; further preferably, the compound is any one of structures represented by formula IV (containing cysteine);
Figure BDA0002931122170000022
preferably, the cysteine or cysteine-containing polypeptide of formula I is any one of the structures of formula V:
Figure BDA0002931122170000031
R3 selected from alkanes, cycloalkanes, aryl derivatives or heterocyclic structures, preferably aryl or aryl derivatives, further preferably phenyl, 4-trifluoromethylphenyl, 4-tert-butylphenylTIPS (triisopropylsilyl), naphthalene.
Wherein the concentration of cysteine or cysteine-containing polypeptide in the first solution is 0.05-1.0 mmol/mL, preferably 0.05-0.5 mmol/mL.
Preferably, the first reaction solution further includes an organic base.
Wherein the organic base includes, but is not limited to, pyridine, 2, 6-lutidine, 2, 6-di-tert-butylpyridine, N, N-diisopropylethylamine, triethylenediamine, N, N, N ', N' -tetramethyl ethylenediamine, 4-dimethylaminopyridine, triethylamine.
Wherein, in the first solution, the mole ratio of cysteine or polypeptide containing cysteine to organic alkali is 1:1 to 5, preferably 1:1.5.
wherein the alkynyl functionalization reagent is a compound shown in a formula III;
Figure BDA0002931122170000032
wherein R is3 Selected from alkanes, cycloalkanes, aryl derivatives or heterocyclic structures, preferably aryl or aryl derivatives, more preferably phenyl, 4-trifluoromethylphenyl, 4-tert-butylphenyl, TIPS (triisopropylsilyl), naphthalene.
Wherein, in the second solution, the concentration of the alkynyl functionalization reagent is 0.05-2.0 mmol/mL, and is preferably 0.15-1.0 mmol/mL.
Wherein the molar ratio of the cysteine or the polypeptide containing the cysteine to the alkynyl functionalization reagent is 1:1-5.
Wherein the first solvent and the second solvent are respectively and independently selected from methanol, ethanol, acetone, 1, 4-dioxane, dichloromethane, 1, 2-dichloroethane, N-dimethyl propenyl urea, acetonitrile, N-dimethylformamide, N-dimethylacetamide, water, phosphate buffer, tetrahydrofuran, dimethyl sulfoxide or any combination thereof, and preferably dimethyl sulfoxide.
Wherein the pumping rate of the first solution and the second solution is 1:1.
wherein the micro-channel reactor comprises a feed pump (Baoding Leifu Fluid Technology Co.Ltd, TYD01-01-CE type), a mixing module (with an inner diameter of 0.6 mm), a micro-reactor and a receiver; wherein, the reaction liquid pumped by the feed pump flows into the microreactor for reaction after being mixed by the mixing module, and the reaction is shown in figure 2.
Wherein the mixing module is a Y-shaped or T-shaped mixer.
Wherein the microreactor is of a pore canal structure, the pore canal material is Perfluoroalkoxyalkane (PFA) or polytetrafluoroethylene, the size and the inner diameter of the microreactor are 0.5-1.0 mm, the length is 5-20 m, and the volume is 1-15.7 mL; wherein the inner diameter is preferably 0.6mm, the volume is preferably 1.4mL, and the flow rate is 0.1-2.0 mL/min.
Wherein the temperature of the reaction is room temperature.
Wherein the reaction time is 30s to 2.6 hours, preferably 1min to 60min, more preferably 1min to 30min, still more preferably 1min to 10min, and most preferably 4.7min.
The beneficial effects are that: compared with the prior art, the invention has the following advantages:
(1) The invention relates to a brand-new method for realizing alkynyl functional modification of cysteine and polypeptide thereof, which can realize alkynyl functional modification of cysteine and polypeptide thereof only by adding organic alkali into a reaction system.
(2) According to the invention, a catalyst is not required, and alkynyl functional modification of cysteine and polypeptide thereof can be realized under the condition of room temperature, so that the problem that a transition metal catalyst is required in the prior art is solved, and the reaction cost and the energy consumption cost are reduced.
(3) The system has the advantages of no solid insoluble matters, no microchannel blocking problem, simple operation, high safety, short reaction time, high reaction conversion rate and yield, and high reaction continuity, and is beneficial to continuous and uninterrupted amplified production, and the defects of the traditional method are overcome.
(4) The invention can realize the synthesis of polypeptide derivatives besides single amino acid derivatives.
(5) The raw material conversion rate of the invention is 88% -100%, and the product yield is as high as 83% -95%.
Drawings
The foregoing and/or other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings and detailed description.
FIG. 1 is a schematic illustration of the reaction scheme of the present invention.
FIG. 2 is a schematic diagram of a microchannel reactor apparatus.
FIG. 3 is a graph of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (phenylethynyl) -L-cysteine methyl ester hydrogen.
FIG. 4 is a chart of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (phenylethynyl) -L-cysteine methyl ester carbon.
FIG. 5 is a graph of N- ((tert-butoxycarbonyl) -L-tryptophan) -S- (phenylethynyl) -L-cysteine methyl ester hydrogen.
FIG. 6 is a chart of N- ((tert-butoxycarbonyl) -L-tryptophan) -S- (phenylethynyl) -L-cysteine methyl ester.
FIG. 7 is a graph of N- ((tert-butoxycarbonyl) -L-tyrosyl) -S- (phenylethynyl) -L-cysteine methyl ester hydrogen.
FIG. 8 is a carbon diagram of N- ((tert-butoxycarbonyl) -L-tyrosyl) -S- (phenylethynyl) -L-cysteine methyl ester.
FIG. 9 is a hydrogen spectrum of N- ((tert-butoxycarbonyl) -L-glutamyl) -S- (phenylethynyl) -L-cysteine methyl ester.
FIG. 10 is a chart of N- ((tert-butoxycarbonyl) -L-glutamyl) -S- (phenylethynyl) -L-cysteine methyl ester.
FIG. 11 is a hydrogen spectrum of N- (t-butoxycarbonyl) pentyl-L-prolyl-S- (phenylethynyl) -L-cysteine methyl ester.
FIG. 12 is a chart of N- (t-butoxycarbonyl) pentyl-L-prolyl-S- (phenylethynyl) -L-cysteine methyl ester carbon.
FIG. 13 is a graph of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (((4- (trifluoromethyl) phenyl) ethynyl) -L-cysteine methyl ester hydrogen.
FIG. 14 is a chart of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (((4- (trifluoromethyl) phenyl) ethynyl) -L-cysteine methyl ester carbon.
FIG. 15 is a fluorine spectrum of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (((4- (trifluoromethyl) phenyl) ethynyl) -L-cysteine methyl ester.
FIG. 16 is a graph of the hydrogen spectrum of methyl N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (((4- (tert-butyl) phenyl) ethynyl) -L-cysteine.
FIG. 17 is a chart of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (((4- (tert-butyl) phenyl) ethynyl) -L-cysteine methyl ester carbon.
FIG. 18 is a graph of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- ((triisopropylsilyl) ethynyl) -L-cysteine methyl ester hydrogen.
FIG. 19 is a chart of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- ((triisopropylsilyl) ethynyl) -L-cysteine methyl ester.
FIG. 20 is a graph of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (naphthalen-1-ylethynyl) -L-cysteine methyl ester hydrogen.
FIG. 21 is a chart of N- ((tert-butoxycarbonyl) -L-phenylalanyl) -S- (naphthalen-1-ylethynyl) -L-cysteine methyl ester.
FIG. 22 is a graph of N-acetyl-S- (phenylethynyl) -L-cysteine methyl ester hydrogen.
FIG. 23 is a graph of N-acetyl-S- (phenylethynyl) -L-cysteine methyl ester carbon.
Detailed Description
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials, unless otherwise specified, are commercially available.
In the following examples, the flow rates of the first reaction liquid and the second reaction liquid are the same.
Example 1
Figure BDA0002931122170000061
(Boc) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mTo L dimethyl sulfoxide was added 43. Mu.L triethylamine (0.3 mmol,1.5 equiv.) as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 86.7mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), in 90% yield. Characterization data were as follows (fig. 3, fig. 4):1 H NMR(400MHz,Chloroform-d)δ7.41(s,2H),7.36–7.20(m,6H),7.14–6.96(m,3H),4.92(s,2H),4.43(s,1H),3.70(s,3H),3.28(s,2H),3.18–2.92(m,2H),1.40(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.2,169.8,155.4,136.3,131.8,129.2,128.7,128.6,128.5,127.0,122.8,92.8,80.4,78.1,55.7,52.9,52.0,38.1,37.5,28.3.HRMS(ESI)m/z:calcd for C26 H30 N2 O5 SNa[M+Na]+ :505.1768,found:505.1767.
example 2
(tert-Butoxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out, dissolved in 2mL of acetonitrile, and 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of acetonitrile as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, the final product was 81.9mg, yield 85% was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1).
Example 3
(tert-Butoxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide, and 35. Mu.L of 2, 6-lutidine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 80.0mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), yield 83%.
Example 4
1.91g (5.0 mmol,1.0 equiv.) of methyl (t-butoxycarbonyl) -L-phenylpropionyl-L-cysteine was weighed out, dissolved in dimethyl sulfoxide, and 1041. Mu.L of triethylamine (7.5 mmol,1.5 equiv.) was added to prepare 10mL of a solution as a first reaction solution. 3.27g of an alkynyl reagent (7.5 mmol,1.5 equiv.) was weighed out and dissolved in dimethyl sulfoxide to prepare 10mL of a solution as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 100 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 2.12g of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), in 88% yield.
Example 5
Figure BDA0002931122170000081
(tert-Butoxycarbonyl) -L-tryptophanyl-L-cysteine methyl ester 0.0842g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL dimethyl sulfoxide, and 43. Mu.L triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After the reaction is completed, the reaction is carried outThe reaction mixture was extracted with ethyl acetate and saturated brine (3×25 mL), and the organic layers were combined, dried over anhydrous sodium sulfate, and after removal of the solvent by distillation under reduced pressure, the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1) in a yield of 95%. Characterization data were as follows (fig. 5, fig. 6):1 H NMR(400MHz,Chloroform-d)δ8.47(s,1H),7.59(d,J=7.4Hz,1H),7.42–7.23(m,6H),7.20–7.13(m,1H),7.12–7.05(m,1H),7.04–6.87(m,2H),5.20(s,1H),4.83(s,1H),4.51(s,1H),3.61(s,3H),3.38–3.03(m,4H),1.42(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.9,169.8,155.5,136.3,131.7,128.5,128.4,127.5,123.3,122.9,122.2,119.7,118.7,111.4,110.1,92.9,80.3,78.1,52.8,51.8,37.6,31.6,28.3,22.7,14.2.HRMS(ESI)m/z:calcd for C28 H31 N3 O5 SNa[M+Na]+ :544.1877,found:544.1880.
example 6
Figure BDA0002931122170000091
(tert-Butoxycarbonyl) -L-tyrosyl-L-cysteine methyl ester 0.0796g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL dimethyl sulfoxide, and 43. Mu.L triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, the final product was obtained in a yield of 88% by silica gel column chromatography (petroleum ether: ethyl acetate=3:1). Characterization data were as follows (fig. 7, 8):1 H NMR(400MHz,Chloroform-d)δ7.45–7.37(m,2H),7.34–7.25(m,3H),7.07(s,1H),6.99–6.84(m,3H),6.71(d,J=7.6Hz,2H),5.14–4.99(m,1H),4.91(s,1H),4.37(s,1H),3.69(s,3H),3.31–3.19(m,2H),3.07–2.86(m,2H),1.42(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.7,169.9,155.6,155.3,131.7,130.3,128.6,128.5,127.5,122.8,115.7,93.0,80.7,77.9,55.9,53.0,52.0,37.4,31.6,28.3,22.7,14.2.HRMS(ESI)m/z:calcd for C26 H30 N2 O6 SNa[M+Na]+ :521.1717,found:521.1709.
example 7
Figure BDA0002931122170000101
(tert-Butoxycarbonyl) -L-glutamyl-L-cysteine methyl ester 0.0726g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL dimethyl sulfoxide, and 43. Mu.L triethylamine (0.3 mmol,1.5 equiv.) was added as the first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 77.8mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), in 84% yield. Characterization data were as follows (fig. 9, fig. 10):1 H NMR(400MHz,Chloroform-d)δ7.95(s,1H),7.47–7.37(m,2H),7.34–7.24(m,3H),6.55(s,1H),6.17(s,1H),5.74(s,1H),5.01–4.86(m,1H),4.34–4.22(m,1H),3.72(s,3H),3.38–3.18(m,2H),2.43-2.33(m,2H),2.11–1.96(m,2H),1.43(s,9H).13 C NMR(100MHz,Chloroform-d)δ175.7,172.0,170.7,155.9,131.7,128.5,128.4,122.9,93.5,80.2,77.8,53.6,52.9,51.9,37.2,31.7,29.0,28.3.HRMS(ESI)m/z:calcd for C22 H29 N3 O6 SNa[M+Na]+ :486.1669,found:486.1627.
example 8
Figure BDA0002931122170000102
Weighing (tert-butoxycarbonyl) -L-pentyl-L-prolyl0.0862g (0.2 mmol,1.0 equiv.) of L-cysteine methyl ester, dissolved in 2mL of dimethyl sulfoxide, was added 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.) as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 89.2mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), in 84% yield. Characterization data were as follows (fig. 11, fig. 12):1 H NMR(400MHz,Chloroform-d)δ7.60(s,1H),7.43–7.37(m,2H),7.32–7.26(m,3H),5.30(s,1H),4.91–4.83(m,1H),4.70–4.60(m,1H),4.37–4.24(m,1H),3.75–3.67(m,4H),3.62–3.56(m,1H),3.36–3.22(m,2H),2.34(d,J=9.6Hz,1H),2.10–1.93(m,4H),1.43(s,9H),1.03(d,J=6.7Hz,3H),0.96(d,J=6.6Hz,3H).13 C NMR(100MHz,Chloroform-d)δ172.7,171.1,170.1,155.9,131.6,128.4,128.3,123.0,93.1,79.6,77.9,60.0,56.8,52.8,51.9,47.6,37.5,31.6,28.3,27.4,25.1,19.7,17.4.HRMS(ESI)m/z:calcd for C27 H37 N3 O6 SNa[M+Na]+ :554.2295,found:554.2247.
example 9
Figure BDA0002931122170000111
(tert-Butoxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide, and 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1512g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, and the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under the reduced pressure, followed by column chromatography over silica gel (petroleum ether: ethyl acetate=3:1) to give 93.5mg of the final product in 85% yield. Characterization data were as follows (fig. 13, 14, 15):1 H NMR(400MHz,Chloroform-d)δ7.55(d,J=8.3Hz,2H),7.49(d,J=8.1Hz,2H),7.30–7.22(m,3H),7.13(d,J=6.9Hz,2H),7.02(s,1H),4.95(d,J=25.7Hz,2H),4.44(s,1H),3.71(s,3H),3.30(d,J=4.7Hz,2H),3.16–3.00(m,2H),1.40(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.3,169.8,155.4,136.3,131.5,129.9(d,J=32.6Hz,1C),129.2,128.7,127.0,126.7,125.3(8)(d,J=38.5Hz,1),125.3(7)(q,J=3.8Hz,2C),122.5,91.8,81.5,80.4,55.7,52.7,51.9,38.1,37.5,28.2.19 F NMR(376MHz,Chloroform-d)δ62.82.HRMS(ESI)m/z:calcd for C27 H29 F3 N2 O5 SNa[M+Na]+ :573.1641,found:573.1619.
example 10
Figure BDA0002931122170000121
(tert-Butoxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide, and 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1476g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 89.3mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), yield 83%. Characterization data were as follows (fig. 16, fig. 17):1 H NMR(400MHz,Chloroform-d)δ7.39–7.30(m,4H),7.28–7.20(m,3H),7.13–7.02(m,3H),4.92(s,2H),4.43(s,1H),3.71(s,3H),3.27(d,J=4.3Hz,2H),3.20–3.12(m,1H),3.01–2.88(m,1H),1.40(s,9H),1.30(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.2,169.9,155.3,152.0,136.5,131.7,129.2,128.7,127.0,125.5,119.8,93.3,80.4,55.7,52.9,52.1,38.1,37.5,34.8,31.2,28.2.HRMS(ESI)m/z:calcd for C30 H39 N2 O5 SNa[M+Na]+ :561.2394,found:561.2360.
example 11
Figure BDA0002931122170000122
(tert-Butoxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide, and 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1548g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 96.7mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), in 86% yield. Characterization data were as follows (fig. 18, fig. 19):1 H NMR(400MHz,Chloroform-d)δ7.30(t,J=7.2Hz,2H),7.25(d,J=7.1Hz,1H),7.20(d,J=7.0Hz,2H),6.76(s,1H),5.02(s,1H),4.84–4.76(m,1H),4.48–4.32(m,1H),3.75(s,3H),3.28–3.11(m,1H),3.15–3.06(m,3H),1.41(s,9H),1.07(s,21H).13 C NMR(100MHz,Chloroform-d)δ171.2,169.9,155.3,136.3,129.3,128.7,127.0,98.2,94.1,80.3,55.5,52.8,51.7,38.1,28.3,18.6,11.3.HRMS(ESI)m/z:calcd for C29 H46 SiN2 O5 SNa[M+Na]+ :585.2789,found:585.2757.
example 12
Figure BDA0002931122170000131
Weighing (t-butyl)Oxycarbonyl) -L-phenylpropionyl-L-cysteine methyl ester 0.0764g (0.2 mmol,1.0 equiv.) was dissolved in 2mL dimethyl sulfoxide, and 43 μl triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1458g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. After completion of the reaction, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was distilled off under reduced pressure, 88.3mg of the final product was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1), yield 83%. Characterization data were as follows (fig. 20, fig. 21):1 H NMR(400MHz,Chloroform-d)δ8.27(d,J=8.2Hz,1H),7.83(t,J=8.4Hz,2H),7.66(d,J=6.8Hz,1H),7.62–7.56(m,1H),7.55–7.49(m,1H),7.40(t,J=7.7Hz,1H),7.22(q,J=11.0,10.5Hz,3H),7.07(s,1H),7.01(d,J=6.6Hz,2H),4.93(d,J=47.6Hz,2H),4.42(s,1H),3.65(s,3H),3.38(d,J=3.7Hz,2H),3.16–3.07(m,1H),2.96–2.83(m,1H),1.39(s,9H).13 C NMR(100MHz,Chloroform-d)δ171.2,169.8,155.4,136.3,133.4,133.2,130.9,129.2,129.1,128.7,128.4,127.1,127.0,126.6,126.1,125.3,120.5,91.0,82.9,55.7,52.9,52.2,37.9,28.2.HRMS(ESI)m/z:calcd for C30 H32 N2 O5 SNa[M+Na]+ :555.1924,found:555.1915.
example 13
Figure BDA0002931122170000141
Methyl N-acetyl-L-cysteinate (0.0354 g) (0.2 mmol,1.0 equiv.) was weighed out and dissolved in 2mL dimethyl sulfoxide, and 43. Mu.L triethylamine (0.3 mmol,1.5 equiv.) was added as a first reaction solution. 0.1308g of an alkynyl reagent (0.3 mmol,1.5 equiv.) was weighed out and dissolved in 2mL of dimethyl sulfoxide as a second reaction solution. The reaction solution was simultaneously pumped into a microreactor having an inner diameter of 0.6mm at a pumping flow rate of 0.15mL/min and a volume of 1.4mL, and the reaction residence time was 4.7min. TLC detection after the reaction was completed, the reaction was reversedThe reaction mixture was extracted with ethyl acetate and saturated brine (3×25 mL), and the organic layers were combined, dried over anhydrous sodium sulfate, and after the solvent was removed by distillation under the reduced pressure, the resultant was subjected to silica gel column chromatography (petroleum ether: ethyl acetate=3:1) to give 48.2mg of the final product in a yield of 87%. Characterization data were as follows (fig. 22, fig. 23):1 H NMR(400MHz,Chloroform-d)δ7.45–7.37(m,2H),7.36–7.28(m,3H),6.58(s,1H),5.05–4.95(m,1H),3.74(s,3H),3.33(d,J=4.3Hz,2H),2.04(s,3H).13 C NMR(100MHz,Chloroform-d)δ170.4,169.9,131.6,128.6,128.4,122.8,92.8,78.1,53.0,52.2,37.5,23.2.HRMS(ESI)m/z:calcd for C14 H15 NO3 SNa[M+Na]+ :300.0665,found:300.0675.
comparative example 1
Methyl (t-butoxycarbonyl) -L-phenylpropionyl-L-cysteinate 0.0764g (0.2 mmol,1.0 equiv.) was weighed out, 0.1308g of alkynyl reagent (0.3 mmol,1.5 equiv.) was added to a Schlenk reaction tube, replaced with argon three times, and then added to 2mL of dimethyl sulfoxide and 43. Mu.L of triethylamine (0.3 mmol,1.5 equiv.). After completion of the reaction at room temperature, TLC was performed, the reaction solution was extracted with ethyl acetate and saturated brine (3X 25 mL), the organic layers were combined, dried over anhydrous sodium sulfate, and after removal of the solvent by distillation under reduced pressure, the final product was 79.0mg, yield 82% was obtained by silica gel column chromatography (petroleum ether: ethyl acetate=3:1).
The invention provides a thought and a method for realizing alkynyl functional modification of cysteine and polypeptide thereof by utilizing a microchannel reactor, and the method and the way for realizing the technical scheme are numerous, the above is only a preferred embodiment of the invention, and it should be pointed out that a plurality of improvements and modifications can be made by those skilled in the art without departing from the principle of the invention, and the improvements and the modifications are also considered as the protection scope of the invention. The components not explicitly described in this embodiment can be implemented by using the prior art.

Claims (8)

1. A method for performing alkynyl functionalization of cysteine-containing polypeptides using a microchannel reactor, comprising the steps of:
(1) Dissolving a polypeptide containing cysteine shown in a formula I in a first solvent to obtain a first reaction solution; the first reaction liquid also comprises organic alkali;
(2) Dissolving an alkynyl functionalization reagent shown in a formula III in a second solvent to obtain a second reaction solution;
(3) Pumping the first reaction liquid and the second reaction liquid into a micro-channel reactor respectively and simultaneously for reaction, and collecting effluent liquid to obtain a reaction liquid containing an alkynyl functionalized product of the polypeptide containing cysteine shown in the formula II;
Figure QLYQS_1
wherein,,
R1 is methyl;
R2 any one selected from structures shown in a formula IV;
Figure QLYQS_2
R3 selected from phenyl, 4-trifluoromethylphenyl, 4-tert-butylphenyl, triisopropylsilyl, or naphthalene;
the concentration of the polypeptide containing cysteine in the first reaction solution is 0.05-1.0 mmol/mL; the molar ratio of cysteine-containing polypeptide to organic base is 1: 1-5;
in the second reaction solution, the concentration of the alkynyl functional reagent is 0.05-2.0 mmol/mL.
2. The method according to claim 1, wherein the concentration of the cysteine-containing polypeptide in the first reaction solution is 0.05 to 0.5mmol/mL.
3. The method according to claim 1, wherein the molar ratio of cysteine-containing polypeptide to organic base in the first reaction solution is 1:1.5.
4. the method of claim 1, wherein the concentration of the alkynyl functionalizing agent in the second reaction solution is 0.15 to 1.0mmol/mL.
5. The method of claim 1, wherein the first solvent and the second solvent are each independently selected from methanol, ethanol, acetone, 1, 4-dioxane, methylene chloride, 1, 2-dichloroethane, N-dimethyl propenyl urea, acetonitrile, N-dimethylformamide, N-dimethylacetamide, water, phosphate buffer, tetrahydrofuran, dimethylsulfoxide, or any combination thereof.
6. The method of claim 1, wherein the first and second reaction fluids are pumped at a rate of 1:1.
7. the method of claim 1, wherein the temperature of the reaction is room temperature.
8. The method of claim 1, wherein the reaction time is 30s to 2.6 hours.
CN202110148412.XA2021-02-032021-02-03 A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptideActiveCN112940071B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202110148412.XACN112940071B (en)2021-02-032021-02-03 A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202110148412.XACN112940071B (en)2021-02-032021-02-03 A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide

Publications (2)

Publication NumberPublication Date
CN112940071A CN112940071A (en)2021-06-11
CN112940071Btrue CN112940071B (en)2023-06-23

Family

ID=76242087

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202110148412.XAActiveCN112940071B (en)2021-02-032021-02-03 A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide

Country Status (1)

CountryLink
CN (1)CN112940071B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN113912525B (en)*2021-10-252023-08-01深圳湾实验室坪山生物医药研发转化中心Probe for modifying protein cysteine residue and preparation method thereof
CN114573658A (en)*2022-03-082022-06-03南京工业大学Method for realizing pyridine selective functionalization of cysteine and polypeptide thereof by using microchannel reactor
CN114716367B (en)*2022-04-202024-04-12南京工业大学Method for preparing 4-mercaptopyridine compound by micro-flow field reactor technology

Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111269164A (en)*2020-02-072020-06-12南开大学Ketone compound, preparation method and application thereof, and method for site-directed modification of protein containing cysteine residues or disulfide bonds
CN112047996A (en)*2020-09-142020-12-08北京大学深圳研究生院 A method for selectively modifying cysteine by propargyl sulfonium salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA2707840A1 (en)*2007-08-202009-02-26Allozyne, Inc.Amino acid substituted molecules
EP3033625B1 (en)*2013-08-132020-01-22The Scripps Research InstituteCysteine-reactive ligand discovery in proteomes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111269164A (en)*2020-02-072020-06-12南开大学Ketone compound, preparation method and application thereof, and method for site-directed modification of protein containing cysteine residues or disulfide bonds
CN112047996A (en)*2020-09-142020-12-08北京大学深圳研究生院 A method for selectively modifying cysteine by propargyl sulfonium salt

Also Published As

Publication numberPublication date
CN112940071A (en)2021-06-11

Similar Documents

PublicationPublication DateTitle
CN112940071B (en) A method of using microchannel reactor to realize alkyne group functionalization of cysteine and its polypeptide
Li et al.Regioselective and stereoselective sulfonylation of alkynylcarbonyl compounds in water
CN113307766B (en)Method for synthesizing pyridine compound by using microchannel reaction device
CN111560624B (en) A kind of method that utilizes microchannel reaction device to continuously prepare isobenzofuran compounds
CN113444752B (en) A method for continuously preparing 2-benzylisoindolinone compounds using a microchannel reactor
WO2022252404A1 (en)Fluorosulfonyl free radical reagent, and preparation method therefor and use thereof
Qin et al.Electrochemical difunctionalization of alkenes
CN111187191A (en)Method for preparing amino acid derivative by using photocatalytic microchannel
CN112410809A (en) A method for electrocatalyzing indole to synthesize fluorine-containing quinolinones using an electrochemical microchannel reaction device
CN113481524B (en)Preparation method for electrochemically synthesizing 3-trifluoromethyl coumarin compound
CN113943252A (en)Pyrazolidinesulfonyl fluoride compounds and preparation method thereof
CN111269155B (en) A kind of synthetic method of alkenyl sulfone compound under metal-free condition
CN119059965A (en) A continuous synthesis method of 4-(pyridin-2-yl)morpholine
CN116891452A (en) Multi-substituted α,β-unsaturated sulfinolactone and preparation method thereof
Zhang et al.TBHP‐Mediated Hydroxyperfluoroalkylation of Alkenes with Perfluoroalkyl Iodides to Construct β‐Perfluoroalkyl Alcohols
CN109134320A (en)A kind of synthetic method of the sulphonyl class compound replaced containing beta-hydroxy
CN116651338A (en)Continuous flow reactor and gas-liquid reaction process
CN112500357B (en) A kind of synthetic method of 1,1-diamino-2,2-dinitroethylene (FOX-7)
CN112876330B (en)Method for continuously preparing bibenzyl by using microchannel reaction device
CN114752954A (en)Method for continuously preparing alkylated isoquinolinone compounds by using microchannel reaction device
CN116396353A (en)Method for realizing trifluoromethylation of cysteine and polypeptide containing cysteine residue by utilizing micro-flow field reaction device
CN113816908A (en)Method for realizing alkylation of histidine or polypeptide thereof by using micro-channel photoreaction technology
CN114213312A (en)Synthesis method of visible light promoted 3-selenocyanoindole compound
CN113861228A (en) A kind of alkylborane derivative and synthetic method thereof
CN115677711B (en)Method for preparing spiro oxindole natural product Spirotryprostatin A

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp